In line with this assumption, staining of tissue sections derived from the mouse model revealed 44% Ki67-positive in the primary tumor, while recurrent tumors with decreased immunoreactivity for Mybbp1a showed a prominent reduction of Ki67 staining (14% of the total cells; Additional file 2: Figure S1). This evidence concerns the gene MKI67 and neoplasm.